Related Experiment Video
Updated: Aug 9, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Does elevated peak bilirubin protect from retinopathy of prematurity in very low birthweight infants
Joshua D Milner1, Hany Z Aly, Laura B Ward
1Department of Pediatrics, Children's National Medical Center, Washington, DC, USA.
Insights
High bilirubin levels in premature infants may increase the risk of retinopathy of prematurity (ROP). This study found elevated peak bilirubin levels were associated with an increased risk for ROP stages III and IV in very low birthweight (VLBW) infants.
Area of Science:
- Neonatal Medicine
- Ophthalmology
- Biochemistry
Background:
- Bilirubin is a known in vitro antioxidant, but its in vivo role remains unclear.
- Very low birthweight (VLBW) infants commonly exhibit elevated bilirubin levels.
- Retinopathy of prematurity (ROP) is a significant concern in VLBW infants, potentially linked to oxidative stress.
Purpose of the Study:
- To investigate the association between peak serum bilirubin levels and the incidence of ROP in VLBW infants.
- To determine if bilirubin's antioxidant properties offer protection against ROP in this vulnerable population.
Main Methods:
- Retrospective analysis of ROP risk (stages III and IV) in VLBW infants based on peak bilirubin levels.
- Logistic regression analysis controlled for birthweight and intraventricular hemorrhage (IVH).
- Subgroup analysis of infants with prolonged oxygen requirements (≥28 days).
Main Results:
- Elevated peak bilirubin levels were associated with an increased risk of ROP stages III and IV (OR 1.187; p=0.034).
- No significant association was found between peak bilirubin and ROP in infants with prolonged oxygen requirement.
- In the prolonged oxygen subgroup, elevated bilirubin was associated with a longer duration of oxygen requirement (p=0.034).
Conclusions:
- Elevated peak bilirubin levels in VLBW infants do not appear to protect against ROP.
- High bilirubin levels may represent a risk factor for developing ROP in VLBW infants.
- Further research is needed to elucidate the complex relationship between bilirubin, oxygen exposure, and ROP.
Objective:
Bilirubin is a potent in vitro antioxidant. Despite repeated study, its in vivo significance has yet to be defined. Bilirubin is universally elevated in very low birthweight (VLBW) infants. Retinopathy of prematurity (ROP) is a disease thought to be associated with exposure to oxygen free radicals in VLBW infants. The objective of this study was to determine whether there was an association between peak bilirubin levels and ROP.
Methods:
The risk for ROP, stages III and IV was measured as a function of increasing peak bilirubin levels in VLBW infants admitted to the neonatal ICU. A similar analysis was performed on a subgroup of VLBW infants with prolonged (> or =28 days) oxygen requirement. The relation between peak bilirubin level and the duration of oxygen requirement was tested by logistic regression analysis. All analyses were conducted after controlling for birthweight and presence of intraventricular hemorrhage (IVH).
Results:
There was an increased risk for ROP, stages III and IV (OR 1.187; 95% CI 1.013 to 1.390; p=0.034) with elevated peak serum bilirubin levels in the entire population. Duration of oxygen requirement was not related to peak bilirubin (p>0.1). In the subgroup of infants with prolonged oxygen requirement (> or =28 days), there was no association between peak serum bilirubin levels and ROP III and IV (p>0.1); however, there was an association with further increased duration of oxygen requirement (p=0.034).
Conclusion:
Elevated peak bilirubin does not protect from and may be a risk for ROP in VLBW infants.
Related Concept Videos
Diabetic Retinopathy
Jaundice

